WOW!
the right of a mentally competent, terminally ill adult patient to access potentially life-saving post-Phase I investigational new drugs, upon a doctor’s advice, even where that medication carries risks for the patient.
I’m not convinced that such a ruling would weather a Supreme Court review, but it certainly puts a dent into FDA’s power, which would be welcome news in my opinion. Orin Kerr has a bit more.
No comments:
Post a Comment